Table of Contents 1 154

ATS 2020 Advance Program

COVER 1
INSIDE COVER 2
TABLE OF CONTENTS 3
BENEFACTOR, PATRON, SUPPORTS & FRIENDS 4
CONFERENCE PLANNERS DISCLOSURES 5
FRIDAY, MAY 15 7
PG1A CRITICAL CARE ULTRASOUND AND ECHOCARDIOGRAPHY I 7
PG2 PEDIATRIC DIAGNOSTIC, ADVANCED DIAGNOSTIC, AND INTERVENTIONAL BRONCHOSCOPY 8
PG3 UPDATE IN ADULT AND PEDIATRIC PULMONARY AND CRITICAL CARE PROCEDURES: HANDS-ON TRAINING FOR BEST PRACTICES 9
PG4 ASTHMA: LATEST TECHNIQUES AND TOOLS FOR THE INVESTIGATOR 10
PG5 INTERSTITIAL LUNG DISEASE: DELIVERING OPTIMAL, PATIENT CENTERED CARE 11
PG6 COPD 2020: STATE OF THE ART 12
PG7 PLEURAL DISEASE IN 2020: WHAT’S NEW? 14
PG8 A PHYSIOLOGIC APPROACH TO RESPIRATORY FAILURE: PRACTICAL PRINCIPLES FOR MANAGEMENT 15
PG9 A HANDS-ON INTRODUCTION TO STUDYING THE LUNG MICROBIOME 16
PG10 BRONCHIECTASIS AND PULMONARY NONTUBERCULOUS MYCOBACTERIA INFECTION 2020 17
PG11 PULMONARY HYPERTENSION IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: A CLOSER LOOK AT THE LEFT HEART 18
PG12 HOW THE EXTRACELLULAR MATRIX INSTRUCTS LUNG REGENERATION: TRANSLATING TOOLS AND TECHNIQUES 19
PG13 SLEEP DISTURBANCES ACROSS VARIOUS MEDICAL DISORDERS 20
PG14 PFT 2020 FOCUS: UPDATES IN CLINICAL PULMONARY FUNCTION AND EXERCISE TESTING 21
SATURDAY, MAY 16 23
PG1B CRITICAL CARE ULTRASOUND AND ECHOCARDIOGRAPHY II 23
PG15 BRONCH DAY 2020: A COMPREHENSIVE, HANDS-ON GUIDE TO BASIC BRONCHOSCOPY, EBUS, AND NAVIGATIONAL BRONCHOSCOPY 24
PG16 ADVANCES IN THE MANAGEMENT OF CHRONIC RESPIRATORY FAILURE SYNDROMES: STATE OF THE ART NONINVASIVE VENTILATION AND MECHANICAL AIRWAY CLEARANCE 25
PG17 A PRACTICAL, HANDS-ON INTRODUCTION TO GENOMIC ANALYSIS IN PULMONARY MEDICINE 27
PG18 THORACIC IMAGING FOR THE PULMONOLOGIST AND CRITICAL CARE PHYSICIAN 28
PG19 INTERSTITIAL LUNG DISEASE: UPDATE AND EVOLVING TRENDS IN DIAGNOSIS AND MANAGEMENT 29
PG20 DOES MY PATIENT HAVE ENVIRONMENTAL OR OCCUPATIONAL LUNG DISEASE? 30
PG21 ADVANCES IN THE DIAGNOSIS AND MANAGEMENT OF PEDIATRIC SEVERE ASTHMA 31
PG22 PEDIATRIC PULMONARY PHYSIOLOGY IN THE ICU 32
PG23 DIFFICULT CLINICAL QUESTIONS IN PULMONARY AND CRITICAL CARE INFECTIONS 33
PG24 FULL CIRCLE OF PULMONARY EMBOLISM (PE) CARE: ACUTE TO CHRONIC AND EVERYTHING IN BETWEEN 34
PG25 PULMONARY REHABILITATION: CREATING AN EFFECTIVE PROGRAM 36
PG26 JUMP START: A BEGINNER’S GUIDE TO DRUG AND COMPANY DEVELOPMENT AND IN AN ACADEMIC SETTING 37
PG27 INTERACTIVE PHYSIOLOGY: HEMODYNAMICS 38
PG28 STATE OF THE ART: LUNG CANCER IN 2020 39
OPENING CEREMONY 41
THE NETWORKING EXCHANGEFOR EARLY CAREER PROFESSIONALS 41
SUNDAY MORNING, MAY 17 42
K1 THE LATEST FROM THE CDC ON E-CIGARETTE, OR VAPING, PRODUCT-USE ASSOCIATED LUNG INJURY (EVALI), YOUTH E-CIGARETTE USE, AND THE EVOLVING POLICY ENVIRONMENT 42
A1 CLINICAL YEAR IN REVIEW 1 42
A2 JAMA AND THE NEW ENGLAND JOURNAL OF MEDICINE. DISCUSSION ON THE EDGE: REPORTS OF RECENTLY PUBLISHED PULMONARY RESEARCH 42
A3 EARLY COPD: GETTING TO THE ROOT OF THE PROBLEM 43
A4 THE NEW ERA OF CRITICAL CARE FOR CANCER PATIENTS: CELLS TO SYSTEMS 43
A5 LUNG REGENERATION: WHAT DO WE WANT? 44
A6 CONTROVERSIES IN SLEEP APNEA PATHOPHYSIOLOGY DEBATE 45
A7 SYSTEMS BIOLOGY PLATFORMS FOR DRUG REPURPOSING IN PULMONARY HYPERTENSION AND BEYOND 45
A8 PRECISION MEDICINE IN PEDIATRIC RESPIRATORY DISEASES: READY FOR PRIME TIME? 46
A9 SEX, LUNGS, AND ENVIRONMENTAL EXPOSURES 47
A10 LINKING LUNG DEVELOPMENT AND CARCINOGENESIS: FROM PATHWAYS TO LUNGMAP AND THE PRECANCER ATLAS 48
A11 BEYOND REPRESENTATION: ACHIEVING GENDER EQUITY IN ACADEMIC MEDICINE 49
A12 PALLIATIVE CARE IN CHRONIC RESPIRATORY DISEASE: A STATE OF THE SCIENCE 49
SUNDAY MID-DAY, MAY 17 51
ATS DIVERSITY FORUM 51
PCC1 PEDIATRIC CLINICAL CORE CURRICULUM 51
WS1 DIAGNOSING AND TREATING MICROAGGRESSIONS IN YOUR HEALTH CARE TEAM 51
WS2 BABY, BABY, BABY: EXPLORING OBSTRUCTIVE SLEEP APNEA IN INFANTS 52
L1 OPPORTUNITIES FOR RESEARCH FUNDING 53
L2 NEW VA PROGRAM IN PRECISION ONCOLOGY FOR LUNG CANCER CARE AND RESEARCH 54
L3 SEPSIS RESEARCH AT THE NIH 55
L4 INHALATION THERAPY FOR NON-TUBERCULAR MYCOBACTERIAL PULMONARY INFECTIONS 55
L5 FDA REAL WORLD EVIDENCE PROGRAM UPDATE 56
L6 UPDATE ON NON-INFECTIOUS RESPIRATORY HAZARDS IN HEALTH CARE 56
L7 NEW FINDINGS FROM THE NHLBI PVDOMICS PROGRAM IN PATIENTS WITH PULMONARY HYPERTENSION 57
L8 UPDATES FROM THE COPDGENE STUDY 57
L9 THE PEDIATRIC PULMONARY VASCULAR DISEASE (PVD) REGISTRY: METHODS, RESULTS AND IMPLICATIONS 58
L10 A NEW APPROACH TO CLINICAL TRIALS FOR PRECISION INTERVENTIONS IN SEVERE ASTHMA 59
MEET THE PROFESSOR SEMINARS 59
ME1 APPROACHES TO DEALING WITH A STRUGGLING LEARNER 60
SUNDAY AFTERNOON, MAY 17 61
A81 NURSING YEAR IN REVIEW: COMPLEMENTARY HEALTH APPROACHES FOR PATIENT-REPORTED SYMPTOMS IN PULMONARY, CRITICAL CARE, AND SLEEP MEDICINE 61
A82 UNDERSTANDING INTERSTITIAL LUNG DISEASE THROUGH MULTI-DIMENSIONAL BIOMARKERS 62
A83 GREAT CASES: CLINICAL RADIOLOGIC, AND PATHOLOGIC CORRELATIONS BY MASTER PHYSICIANS 62
A84 THE NEW ENGLAND JOURNAL OF MEDICINE AND JAMA. DISCUSSION ON THE EDGE: REPORTS OF RECENTLY PUBLISHED CRITICAL CARE RESEARCH 63
A85 LUNG REGENERATION: HOW DO WE GET THERE? 63
A86 BUILDING RESPIRATORY EPITHELIUM AND TISSUE FOR HEALTH (BREATH): ORGANOIDS AND ENGINEERING 64
A87 CONTROVERSIES IN PEDIATRIC PULMONOLOGY 64
A88 THREE IN ONE: UPDATES ON ASTHMA MANAGEMENT FROM 3 GUIDELINE COMMITTEES 65
A89 BACTERIOPHAGE THERAPY OF COMPLEX PULMONARY INFECTIONS 66
A90 EMERGING DANGERS FROM E-CIGARETTES: LET’S HAVE A VAPE DEBATE 67
A91 ATS CLINICAL PRACTICE GUIDELINES: CLINICAL PRACTICE ON THE CUTTING EDGE 67
SUNDAY AWARDS SESSSION 69
ASSEMBLY MEMBERSHIP MEETINGS 70
ASSEMBLY ON PEDIATRICSFOUNDERS DINNER 70
SECTION ON GENETICS AND GENOMICSMEMBERSHIP MEETING 70
MONDAY MORNING, MAY 18 71
SUNRISE SEMINARS 71
K2 OBESITY-HYPOVENTIALTION SYNDROME: LESSONS FROM THE PICKWICK PAPERS 72
B1 CLINICAL YEAR IN REVIEW 2 72
B2 WHEN CF BECOMES NON-CF BRONCHIECTASIS: THE ONGOING BATTLE AGAINST INFECTION IN CYSTIC FIBROSIS DURING THE CFTR-MODULATOR ERA 72
B3 FELLOWS CASE CONFERENCE 73
B4 A POSITIVE APPROACH TO NEGATIVE TRIALS: MAKING SENSE OF CONFLICTING TRIALS IN CRITICAL CARE 74
B5 CELLULAR PLASTICITY AND LUNG TISSUE BIOENGINEERING: NOVEL APPROACHES TO ADVANCED RESPIRATORY DISEASE 75
B6 ADVANCING CARE QUALITY FOR ADULT HOME OXYGEN PATIENTS 75
B7 LUNG CANCER SCREENING: SOMETHING OLD, SOMETHINGS NEW, SOMETHING BORROWED, SOMETHING BLUE 76
B8 INFLAMMATION IN ARDS: TOO MUCH OR TOO LITTLE? 77
B9 2020 VISION OF TB 78
B10 EARLY PULMONARY COMPLICATIONS OF PEDIATRIC STEM CELL TRANSPLANT:UPDATE FROM NIH WORKSHOP 78
B11 BEYOND DNA: THE UNSEEN GENOME AND NOVEL OMICS APPROACHES TO PULMONARY HYPERTENSION 79
B12 BREAKING NEWS: CLINICAL TRIAL RESULTS IN PULMONARY MEDICINE 80
B13 CLINICAL PRACTICE 2020: EFFECTIVELY LEARNING, TEACHING, AND SHARING MEDICAL INFORMATION 80
MONDAY MID-DAY, MAY 18 81
ATS WOMEN’S FORUM 81
PCC2 PEDIATRIC CLINICAL CORE CURRICULUM 82
WS3 IMPROVING YOUR ACADEMIC FOOTPRINT USING DIGITAL SCHOLARSHIP: THE MYTH OF SOCIAL MEDIA 82
WS4 CLOSING THE QUALITY GAP IN MALIGNANT PLEURAL EFFUSION 83
CC2 PULMONARY CLINICAL CORE CURRICULUM I 84
L11 PULMONARY REHABILITATION IN VA: OPPORTUNITIES AND CHALLENGES FOR HOME-BASED PROGRAMS 84
L12 PULMONARY HEALTH IMPACTS OF E-CIGARETTES AND VAPING: WHAT’S EMERGING? 85
L13 PREVENTING HOSPITALIZATIONS AND ED VISITS IN CHILDREN WITH ASTHMA 85
L14 GENERIC DRUG DEVELOPMENT FOR RESPIRATORY PRODUCTS: U.S. FOOD AND DRUG ADMINISTRATION UPDATE 86
L15 SYSTEMS BIOLOGY FOR ACUTE RESPIRATORY INFECTIONS 87
L16 THE LUNGAGING PROJECT: A SINGLE CELL MULTI-OMICS NORMAL LUNG AGING REFERENCE ATLAS 87
L17 NEW FINDINGS FROM THE SUBPOPULATIONS AND INTERMEDIATE OUTCOME MEASURES IN COPD (SPIROMICS) STUDY 88
L18 LESSONS LEARNED IN NHLBI ASTHMA EMPOWERMENT CLINICAL TRIALS: COMMUNITY AND SCHOOL ENGAGEMENT 88
L19 NHLBI PREVENTION AND EARLY TREATMENT OF ACUTE LUNG INJURY (PETAL) NETWORK 89
L20 AMERICAN LUNG ASSOCIATION AIRWAYS CLINICAL RESEARCH CENTERS LUNG HEALTH COHORT STUDY 90
MEET THE PROFESSOR SEMINARS 90
ME2 COACHING RESILIENCY AND GRIT IN PULMONARY AND CRITICAL CARE MEDICINE 91
MONDAY AFTERNOON, MAY 18 92
PRESENTATION OF THE RECOGNITION AWARDS FOR SCIENTIFIC ACCOMPLISHMENTS 92
CC3 CRITICAL CARE CLINICAL CORE CURRICULUM II 92
B81 PEDIATRIC YEAR IN REVIEW 93
B82 ROLE OF SURGERY FOR PLEURAL DISEASES IN 2020: WHAT PULMONOLOGISTS NEED TO KNOW 93
B83 EARLY DETECTION AND DIAGNOSIS OF IDIOPATHIC PULMONARY FIBROSIS 94
B84 EARLY SEPSIS CARE AND THE HOUR ONE BUNDLE: WHY? WHEN? WHO? HOW? 95
B85 THE RARE AND THE FEW: NEWLY IDENTIFIED CELL TYPES IN THE LUNG AND IMPLICATIONS FOR DISEASE AND REGENERATION 96
B86 DELIVERY OF PULMONARY REHABILITATION IN THE FACE OF SOCIAL AND HEALTH INEQUALITY: CAN WE BRIDGE THE GAP? 96
B87 SLEEP CLINIC 2030: BIG DATA, WEARABLES AND DEEP LEARNING CHANGE SLEEP MEDICINE 97
B88 MIND THE GAP: ENDING GENDER DISCRIMINATION AND SEXUAL HARASSMENT IN CRITICAL CARE 98
B89 UNLOCKING THE POTENTIAL OF TRAINED IMMUNITY TO TREAT RESPIRATORY INFECTION AND INFLAMMATION 99
B90 SMOKE SIGNALS: WILDFIRE EXPOSURE AND PULMONARY HEALTH OUTCOMES 100
B91 ORIGINS OF COPD: SUSCEPTIBILITY OF DIFFERENT CELL TYPES 100
B92 ATS JOURNALS 2020 AND BEYOND: TRANSFORMATIONS IN MEDICAL PUBLISHING FOR AUTHORS AND READERS 101
ASSEMBLY MEMBERSHIP MEETINGS 103
ASSEMBLY DINNER/RECEPTION 104
TUESDAY MORNING, MAY 19 105
SUNRISE SEMINARS 105
K3 VACCINES ON THE HORIZON: IMPLICATIONS FOR PRACTICE AND POLICY 106
C1 CLINICAL YEAR IN REVIEW 3 106
C2 LUNG COMPLICATIONS AFTER HEMATOPOIETIC CELL TRANSPLANT 106
C3 PEDIATRIC CLINICAL CHEST ROUNDS 107
C4 EVERYTHING YOU WANTED TO KNOW ABOUT CARING FOR CRITICALLY ILL GERIATRIC PATIENTS 108
C5 CLINICAL CONTROVERSIES IN PULMONARY HYPERTENSION: A PRO/CON DEBATE 108
C6 AN INTEGRATED SYSTEM: IMPACTS OF SKELETAL MUSCLE AND CARDIAC PHYSIOLOGY IN COPD 109
C7 DECIPHERING THE ALVEOLAR PUZZLE: CELLS IN THE DISTAL LUNG DURING INJURY AND AGING 110
C8 IMPLEMENTATION SCIENCE IN THE ICU 2.0: BEYOND BARRIERS AND FACILITATORS 111
C9 POST-INFECTION LUNG REGENERATION AND REPAIR 112
C10 BUILDING GLOBAL ADVOCACY TO ADVANCE GLOBAL LUNG HEALTH 112
C11 EVOLVING KNOWLEDGE OF THE EFFECT OF CANNABIS AND CANNABINOIDS ON THE LUNG 113
C12 INITIATING PHARMACOLOGIC TREATMENT OF TOBACCO DEPENDENCE ACROSS THE SPECTRUM 114
TUESDAY MID-DAY, MAY 19 115
ATS PLENARY SESSION 115
PCC3 PEDIATRIC CLINICAL CORE CURRICULUM 116
WS5 USING SOCIODRAMA METHODS TO IMPROVE FAMILY COMMUNICATION AND VALUES FACILITATION IN ICU 116
WS6 REACHING (AND SUCCESSFULLY SAMPLING!) A PERIPHERAL PULMONARY LESION: WHEN IS A TECHNOLOGY READY FOR CLINICAL USE? 117
MEET THE PROFESSOR SEMINARS 118
ME3 TEACHING CRITICAL APPRAISAL OF THE MEDICAL LITERATURE: FROM BOOKMARKS TO BEDSIDE 118
TUESDAY AFTERNOON, MAY 19 119
CC4 PULMONARY CLINICAL CORE CURRICULUM II 119
C82 PHENOTYPING ACUTE EXACERBATIONS OF COPD 120
C83 THE ROLE OF LUNG MICROBIOME IN INTERSTITIAL LUNG DISEASES: STATE OF THE ART AND FUTURE DIRECTIONS 121
C84 HAS THE PENDULUM SWUNG TOO FAR? EVALUATING CURRENT PRACTICES IN CRITICAL CARE 121
C85 SCIENTIFIC BREAKTHROUGHS: NEW VIEWS OF TISSUE REGENERATION 122
C86 ATS MYTHBUSTERS: NOVEL SINGLE CELL PROFILING TECHNOLOGIES WILL HAVE A SIGNIFICANT IMPACT ON THE UNDERSTANDING AND MANAGEMENT OF PULMONARY FIBROSIS 123
C87 PARTNERS IN CRIME: INTERACTION OF SEX DISPARITY, OBESITY, INFECTION AND SMOKING IN PULMONARY VASCULAR DISEASE 124
C88 ADVANCES IN RESPIRATORY DISEASES IN DOWN SYNDROME: BRIDGING BENCH AND BEDSIDE 125
C89 QUANTITATIVE PHYSIOLOGY: MODERN IMAGING TOOLS FOR TACKLING TIMELESS QUESTIONS 125
C90 MODULATING TYPE 2 AIRWAY INFLAMMATION: THINKING OUTSIDE OF IL-4, IL-5, AND IL-13 126
C91 INTEGRATIVE GENOMICS STRATEGIES FOR COMPLEX RESPIRATORY DISEASES 127
C92 UNCOVERING THE HIDDEN CURRICULUM: ADDRESSING IMPLICIT BIAS IN MEDICINE 127
SECTION MEMBERSHIP MEETINGS 128
WEDNESDAY MORNING, MAY 20 129
SUNRISE SEMINARS 129
D1 CLINICAL YEAR IN REVIEW 4 130
D2 ETHICAL CHALLENGES IN CARING FOR PATIENTS WITH ADVANCED CARDIOPULMONARY DISEASE 130
D3 STATE OF THE ART IN RESPIRATORY CARE OF NEUROMUSCULAR DISEASE FROM PEDIATRICS TO ADULT: LIVING LONGER AND LIVING BETTER 131
D4 REDEFINING TIME ZERO: CRITICAL CARE DELIVERY IN THE FIELD, ED, AND WARD 132
D5 MICROBIOME-IMMUNE INTERACTIONS IN ASTHMA 133
D6 GENETIC AND MOLECULAR MECHANISMS OF ABNORMAL LUNG DEVELOPMENT 133
D7 SEEING IS BELIEVING: NOVEL IMAGING APPROACHES TO THE PULMONARY VASCULATURE AND RV 134
D8 THE MATRIX REVEALED: UNDERSTANDING EXTRACELLULAR MATRIX INFLUENCES ON LUNG DISEASES 135
D9 LUNG CANCER RISK ASSESSMENT: CLINICAL MODELS X MOLECULAR BIOMARKERS 136
D10 THE EVOLUTION OF INHALATION: THE BIOLOGIC, PHYSICAL, AND POLICY IMPLICATIONS OF VAPING AND OTHER NOVEL DEVICES 136
D11 HEALTH REFORM AND THE 2020 PRESIDENTIAL ELECTION: MEDICARE FOR ALL, SOME OR NONE? 137
WEDNESDAY MID-DAY, MAY 20 138
PCC4 PEDIATRIC CLINICAL CORE CURRICULUM 138
WS7 NOVEL MOLECULAR-BASED DIAGNOSTICS FOR LUNG INFECTIONS: CLINICAL IMPLEMENTATION AND RESEARCH QUESTIONS 139
WS8 BREATHLESSNESS: NEW INSIGHTS INTO ASSESSMENT, MECHANISMS AND THERAPY 139
CC5 SLEEP MEDICINE CLINICAL CORE CURRICULUM I 140
L21 APPLICATIONS OF NASA’S EARTH OBSERVATION DATA IN RESPIRATORY HEALTH 141
L22 ADVANCING PEDIATRIC PULMONARY AND CRITICAL CARE RESEARCH AT NICHD/NIH 141
L23 THE OPIOID PUBLIC HEALTH CRISIS: SCIENCE = SOLUTIONS 142
L24 PULMONARY UPDATE FROM THE U.S. FOOD AND DRUG ADMINISTRATION 142
L25 IMMUNOMODULATORY THERAPIES IN ASTHMA 143
L26 THE MOLECULAR ATLAS OF LUNG DEVELOPMENT (LUNGMAP), PHASE 2 143
L27 CAPTURE: A NEW APPROACH FOR IDENTIFYING PATIENTS WITH UNDIAGNOSED COPD 144
L28 NHLBI INPATIENT IMPLEMENTATION PROGRAM 145
L29 NHLBI-FUNDED EPIDEMIOLOGICAL COHORT STUDIES IN LUNG HEALTH AND DISEASE 145
WEDNESDAY AFTERNOON, MAY 20 146
CC6 SLEEP MEDICINE CLINICAL CORE CURRICULUM II 146
D82 CONTROVERSIAL TREATMENT STRATEGIES IN COPD: PRO/CON 146
D83 TELOMERES IN INTERSTITIAL LUNG DISEASE AND LUNG TRANSPLANTATION 147
D84 TWENTY YEARS INTO THE LOW TIDAL VOLUME ERA FOR ARDS: WHAT ELSE SHOULD WE BE DOING? 148
D85 ENVIRONMENTAL EXPOSURES AND THE AIRWAY MICROBIOME 149
D86 CUTTING-EDGE DIAGNOSTICS: INTEGRATING MULTI-OMIC PLATFORMS IN THE DIAGNOSIS OF LUNG INFECTIONS 149
D87 REPAIR AND REGENERATION OF THE LUNG: TARGETING STEM CELLS IN CYSTIC FIBROSIS 150
D88 SLEEP DISORDERS: THE NEW RISK FACTOR FOR AGE-RELATED NEURODEGENERATIVE DISEASES? 151
D89 NOVEL THERAPEUTIC MANAGEMENT IN NON-TUBERCULOUS MYCOBACTERIA 152
D90 HORIZONS IN EXTRACORPOREAL SUPPORT: EVIDENCE, ENIGMAS, AND WHAT'S COMING NEXT 152
BACK COVER 154

RkJQdWJsaXNoZXIy MTM1ODMw